Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice

Intravitreal ranibizumab (IVR) has been approved for treating diabetic macular edema (DME), and is used in daily clinical practice. However, the treatment efficacies of IVR monotherapy in real-world clinical settings are not well known. The medical records of 56 eyes from 38 patients who received th...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Sato, Shinri, Shinoda, Hajime, Nagai, Norihiro, Suzuki, Misa, Uchida, Atsuro, Kurihara, Toshihide, Kamoshita, Mamoru, Tomita, Yohei, Iyama, Chigusa, Minami, Sakiko, Yuki, Kenya, Tsubota, Kazuo, Ozawa, Yoko
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2017
Subjects:
5800
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406051/
https://ncbi.nlm.nih.gov/pubmed/28422835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006459
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items